Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Systemic diseases can cause hair loss, which is often reversible with treatment.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Prednisone reduces organ mast cell infiltration but does not alter the abnormal appearance of mast cells in systemic mastocytosis.

Panchkarma treatment can help manage symptoms of Systemic Lupus Erythematous.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

Certain factors can start hair growth in adult skin by making cells communicate and form new hair follicles.

A woman with severe hair loss due to systemic sclerosis regrew her hair in 4 months using a combination of treatments.

Psychological factors play a significant role in developing alopecia areata.

Low iron and L-lysine levels can cause hair loss in women, and increasing these nutrients can reduce hair shedding.

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

Growth factors and cytokines are important for hair growth and could potentially treat hair loss, but more research is needed to overcome challenges before they can be used in treatments.

Growth factors are crucial for hair development and could help treat hair diseases.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Gonadal hormones significantly affect the severity of alopecia areata in mice.